References
- Hyman L. Epidemiology of eye disease in the elderly. Eye. 1987;I: 330–341.
- Wang JJ, Mitchell P, Simpson JM, et al. Visual impairment, age-related cataract and mortality. Arch Ophthalmol. 2001;118:1186–1190.
- Taylor HR, McCarty CA, Nanjan MB. Vision impairment predicts five-year mortality. Trans Am Ophthalmol Soc. 2000;98: 91–96.
- West SK, Munoz B, Istre J, et al. Mixed lens opacities and subsequent mortality. Arch Ophthalmol. 2000;118:393–397.
- Hennis A, Wu SY, Li X, et al. Lens opacities and mortality: the Barbados Eye Studies. Ophthalmology. 2001;108:498–504.
- McKibbin M, Mohammed M, James TE, Atkinson PL. Short-term mortality among middle-aged cataract surgery patients. Eye. 2001; 15:209–212.
- Goodrich ME, Cumming RG, Mitchell P, et al. Plasma fibrinogen and other cardiovascular disease risk factors and cataract. Ophthalmic Epidemiol. 1999;6:279–290.
- Klein BEK, Klein R, Lee KE. Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: the Beaver Dam Eye Study. Am J Ophthalmol. 1997;123:338–346.
- Klein BEK, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998; 126:782–790.
- Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102: 1450–1460.
- Attebo K, Mitchell P, Smith W Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996;103:357–364.
- Mitchell P, Smith W, Wang JJ. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology. 1998;105: 1359–1363.
- Mitchell P, Cumming RG, Attebo K, Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology. 1997;104:581–588.
- Klein BEK, Klein R, Linton KL, et al. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology. 1990;97: 1428–1433.
- Cumming RG, Mitchell P. Alcohol, smoking, and cataracts: the Blue Mountains Eye Study. Arch Ophthalmol. 1997;115:1296–1303.
- Delcourt C, Cristol JP, Tessier F, et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Am J Epidemiol. 2000151: 497–504.
- West SK, Duncan DD, Munoz B, et al. Sunlight exposure and risk of lens opacities in a population- based study: the Salisbury Eye Evaluation project. J Am Med Assoc. 1998;280: 714–718.
- Cumming RG, Mitchell P. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997; 337:8–14.
- Cumming RG, Mitchell P, Lim R. Iris color and cataract: the Blue Mountains Eye Study. Am J Ophthalmol. 2000;130:237–238.
- Rowe N, Mitchell P, Cumming RG, Wang JJ. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2000;7: 103–114.
- Hiller R, Sperduto RD, Podgor MJ, et al. Cigarette smoking and the risk of development of lens opacities. The Framingham studies. Arch Ophthalmol. 1997;115: 1113–1118.
- Klein BEK, Klein R, Ritter LL. Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1993;100:1609–1613.
- West S, Munoz B, Schein OD, et al. Cigarette smoking and risk for progression of nuclear opacities. Arch Ophthalmol. 1995;113: 1377–1380.
- Christen WG, Manson JE, Seddon JM, et al. A prospective study of cigarette smoking and risk of cataract in men. J Am Med Assoc. 1992;268:989–993.
- McCarty CA, Mukesh BN, Fu CL, Taylor HR. The epidemiology of cataract in Australia. Am J Ophthalmol. 1999;128:446–465.
- Hetzel DM. Death, disease and diversity in Australia, 1951 to 2000. Med J Aust. 2001;174: 21–24.
- Zlokovic BY, Mackic JB, McComb JG, et al. Blood-to-lens transport of reduced glutathione in an in situ perfused guinea-pig eye. Exp Eye Res. 1994;59:487–496.
- Sweeney MH, Truscott RJ. An impediment to glutathione diffusion in older normal human lenses: a possible precondition for nuclear cataract. Exp Eye Res. 1998;67: 587–595.
- Glynn RJ, Christen WG, Manson JE, et al. Body mass index. An independent predictor of cataract. Arch Ophthalmol. 1995;113: 1131–1137.
- Schaumberg DA, Glynn RJ, Christen WG, et al. Relations of body fat distribution and height with cataract in men. Am J Guth Nutr. 2000;72:1495–1502.
- Hiller R, Podgor MJ, Sperduto RD, et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology. 1998;105: 1244-125o.
- Klein BE, Klein R, Jensen SC, Linton KL. Hypertension and lens opacities from the Beaver Dam Eye Study. Am J Ophthalmol. 1995;119: 64o–646.
- Hiller R, Sperduto RD, Ederer E Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J EpidemioL 1986;124:916–925.
- Burgess CA, Sowers M. Systemic hypertension and senile cataracts: an epidemiologic study. Optom Vis ScL 1992;69:320–324.
- Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataracts. India-US Case-Control Study Group (published erratum appears in Arch Ophthalmol. 1989;107(9):1288). Arch Ophthalmol. 1989;107: 670–676.
- Tavani A, Negri E, La Vecchia C. Selected diseases and risk of cataract in women. A case-control study from northern Italy. Ann EpidemioL 1995;5:234–238.
- Clayton RM, Cuthbert J, Phillips CI, et al. Analysis of individual cataract patients and their lenses: a progress report. Exp Eye Res. 1980;31: 553–566.
- Kahn HA, Leibowitz HM, Ganley JP. The Framingham Eye Study, I. Outline and major prevalence findings. Am J EpidemioL 1977;106: 17–32.
- Gibson JIM, Shaw DE, Rosenthal AR. Senile cataract and senile macular degeneration: an investigation into possible risk factors. Trans Ophthalmol Soc UK. 1986;105:463–468.
- Schaumberg DA, Glynn RJ, Christen WG, et al. A prospective study of blood pressure and risk of cataract in men. Ann EpidemioL 2001;11:104–110.